News

Fourth Marie Curie Reintegration Grant Funded at the Nencki Institute

The project entitled The Role of the Grhl1 gene in skin cancer will last four years and will be funded by the European Commission to the level of 100 000 Euro. The aims of this project are to further characterize the involvement of PI3K/Akt signaling pathway in skin cancer, and to establish the role of Grhl1 in this pathway. The scientist will also determine whether the Grhl1 gene functions as a tumor suppressor in skin cancer. To achieve these goals, Dr Wilanowski’s group will use a ...

New Laboratory at the Nencki Institute

Dr. Piwocka’s lab will provide core-facility services, high quality expertise and training in flow cytometry for in-house and outside investigators. It will also be involved in research and ...

Inventions from the Nencki Institute

The first invention was created by Andrzej Kubalski PhD and Piotr Koprowski PhD and it is a novel tool for identification of potential antibacterial compounds.

This invention is ...

TEAM Project at the Nencki Institute

The main objective of Dr. Dobrzyn’s project is to elucidate molecular and cellular mechanisms of insulin resistance and of pancreatic beta-cell dysfunction and apoptosis, associated with obesity ...